These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31688381)

  • 21. Acute eosinophilic pneumonia-like syndrome post-initiation of vortioxetine.
    O'Brien TM
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37230747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vortioxetine hydrobromide, crofelemer, and teduglutide.
    Hussar DA; Lye A
    J Am Pharm Assoc (2003); 2014; 54(1):91-4. PubMed ID: 24407747
    [No Abstract]   [Full Text] [Related]  

  • 23. Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary.
    Roman MW; Wilkinson SM
    Issues Ment Health Nurs; 2014 Dec; 35(12):972-4. PubMed ID: 25426751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
    Jain R; Mahableshwarkar AR; Jacobsen PL; Chen Y; Thase ME
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):313-21. PubMed ID: 22963932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
    Baune BT; Sluth LB; Olsen CK
    J Affect Disord; 2018 Mar; 229():421-428. PubMed ID: 29331703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of vortioxetine for the treatment of major depressive disorder.
    Dhir A; Sarvaiya J
    Expert Rev Neurother; 2014 Dec; 14(12):1349-63. PubMed ID: 25418918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
    Levada OA; Troyan AS
    J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levomilnacipran and Vortioxetine for Adults with Major Depressive Disorder.
    Scarff JR
    J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):131-3. PubMed ID: 27141705
    [No Abstract]   [Full Text] [Related]  

  • 29. Vortioxetine-Related Call-Fleming Syndrome.
    Moodliar S; Naguy A; AlKhadhari S
    Am J Ther; 2019 Oct; 28(2):e258-e260. PubMed ID: 31651448
    [No Abstract]   [Full Text] [Related]  

  • 30. Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Li G; Wang X; Ma D
    Clin Drug Investig; 2016 Jul; 36(7):509-17. PubMed ID: 27067232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.
    Keefe RSE; Nomikos G; Zhong W; Christensen MC; Jacobson W
    Int J Neuropsychopharmacol; 2018 May; 21(5):442-447. PubMed ID: 29546401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats.
    Lu Y; Ho CS; McIntyre RS; Wang W; Ho RC
    Brain Res Bull; 2018 Sep; 142():1-7. PubMed ID: 29933036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA).
    Chin CN; Zain A; Hemrungrojn S; Ung EK; Kwansanit P; Au Yong KC; Chong MSW; Inpa C; Yen TH; Yeoh BBD; Tay LK; Bernardo C; Lim LC; Yap CH; Fones C; Nayak A; Nelleman L
    Curr Med Res Opin; 2018 Nov; 34(11):1975-1984. PubMed ID: 29768955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of Meige dystonia induced by short-term quetiapine treatment.
    Nishikawa T; Nishioka S
    Hum Psychopharmacol; 2002 Jun; 17(4):197. PubMed ID: 12404689
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
    Vieta E; Sluth LB; Olsen CK
    J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder.
    Vieta E; Loft H; Florea I
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):877-884. PubMed ID: 28693903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone.
    Umene-Nakano W; Yoshimura R; Hori H; Okamoto T; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):273. PubMed ID: 20849906
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral Facial Dystonia (Meige or Brueghel Syndrome) Induced by Paliperidone Palmitate.
    Marques JG
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28129491
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vortioxetine: a new antidepressant to treat depressive episodes].
    Colle R; Corruble E
    Encephale; 2016 Feb; 42(1):48-58. PubMed ID: 26358483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive Meige syndrome responsive to clozapine.
    Van Putten T; Wirshing WC; Marder SR
    J Clin Psychopharmacol; 1990 Oct; 10(5):381-2. PubMed ID: 1979568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.